# Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses

> **NCT06613334** · NA · RECRUITING · sponsor: **Centre Hospitalier St Anne** · enrollment: 200 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **BIOLOGICAL:** Blood test: measurement of plasma antipsychotic concentration
- **OTHER:** Voice interviews and questionnaires carried out via the CALLYOPE application

## Key facts

- **NCT ID:** NCT06613334
- **Lead sponsor:** Centre Hospitalier St Anne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-04
- **Primary completion:** 2026-10-04
- **Final completion:** 2026-10-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06613334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06613334, "Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06613334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*